Literature DB >> 26769172

Left Ventricular Pacing through Coronary Sinus Is Feasible and Safe for Patients with Prior Tricuspid Valve Intervention.

Skevos Sideris1, Maria Drakopoulou2, George Oikonomopoulos3, Konstantinos Gatzoulis2, George Stavropoulos3, Dimitris Limperiadis3, Konstantinos Toutouzas2, Dimitris Tousoulis2, Ioannis Kallikazaros1.   

Abstract

BACKGROUND: In the presence of tricuspid valve intervention, right ventricular lead implantation is associated with the potential risk of tricuspid valve malfunction leading to a tricuspid regurgitation. Few cases have been reported with successful left ventricular pacing via the coronary sinus (CS) after tricuspid valve replacement or repair. In this retrospective study, we present the long-term clinical outcomes of 17 patients who underwent CS lead implantation and left ventricular pacing.
METHODS: Seventeen consecutive patients referred to our institution with an indication of postprocedural pacemaker (PM) implantation after tricuspid valve intervention were retrospectively included in the study. The indication for device implantation in all patients was atrial fibrillation with a symptomatic pause ≥ 3.0 seconds. Thus, all devices implanted were ventricular rate responsive (VVIR).
RESULTS: All device implantations were successful and uncomplicated. Mean operation time was 60 ± 8 minutes. Mean fluoroscopy time was 8.3 ± 2.1 minutes. Mean R-wave sensing was 7.5 ± 2.0 mV with a mean slew rate of 2.2 V/s. A mean pacing threshold of 1.9 ± 0.3 V/0.4 ms was accepted as patients were not PM-dependent. The pacing impedance was 743.5 ± 109.71 Ohm. At 2-year follow-up, pacing sensing, threshold, and impedance values were unchanged and no lead dislodgement has been noted.
CONCLUSIONS: In patients with tricuspid valve intervention, left ventricular pacing might be the treatment of choice for permanent ventricular pacing, with all the advantages of the endovenous route as a minimally invasive approach. ©2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  coronary sinus; pacing; tricuspid valve prosthesis

Mesh:

Year:  2016        PMID: 26769172     DOI: 10.1111/pace.12815

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

1.  Single- and dual-site ventricular pacing entirely through the coronary sinus for patients with prior tricuspid valve surgery.

Authors:  Chin C Lee; Khuyen Do; Sati Patel; Steven K Carlson; Tomas Konecny; Philip M Chang; Rahul N Doshi
Journal:  J Interv Card Electrophysiol       Date:  2019-08-20       Impact factor: 1.900

2.  Clinical investigation of left ventricular pacing using coronary sinus in patients with mechanical prosthetic tricuspid valve replacement.

Authors:  Kelan Zha; Kaijun Cui; Xingbin Liu; Yuan Fang
Journal:  Clin Cardiol       Date:  2017-11-22       Impact factor: 2.882

3.  Implantation of right ventricular endocardial pacing lead via paravalvular leak and subsequent paravalvular leak closure in a patient with mechanical tricuspid valve.

Authors:  Weiwei Zhang; Xin Pan; Cheng Wang; Lan Ma; Ruogu Li; Ben He
Journal:  HeartRhythm Case Rep       Date:  2022-03-03

4.  Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation.

Authors:  Daniel Reichart; Niklas Schofer; Florian Deuschl; Andreas Schaefer; Stefan Blankenberg; Hermann Reichenspurner; Ulrich Schaefer; Lenard Conradi
Journal:  Thorac Cardiovasc Surg Rep       Date:  2017-09-18

5.  Case presentation: implantation of cardiac resynchronization therapy pacemaker via the coronary sinus in a patient with triple valve replacement.

Authors:  Cheng Zheng; Wei-Qian Lin; Yuan-Zheng Lin; Hao Lian; Zhi-Rui Liu; Jia-Hui Chen; Jia-Feng Lin
Journal:  BMC Cardiovasc Disord       Date:  2018-02-21       Impact factor: 2.298

6.  Left ventricular pacing in patients with preexisting tricuspid valve disease.

Authors:  Tony Y W Li; Swee Chong Seow; Devinder Singh; Wee Tiong Yeo; Pipin Kojodjojo; Toon Wei Lim
Journal:  J Arrhythm       Date:  2019-11-11

7.  Injectable conductive hydrogel can reduce pacing threshold and enhance efficacy of cardiac pacemaker.

Authors:  Zhao An; Jun Wu; Shu-Hong Li; Shanglin Chen; Fang-Lin Lu; Zhi-Yun Xu; Hsing-Wen Sung; Ren-Ke Li
Journal:  Theranostics       Date:  2021-02-06       Impact factor: 11.556

8.  RIght VErsus Left Apical transvenous pacing for bradycardia: Results of the RIVELA randomized study.

Authors:  Haran Burri; Hajo Müller; Richard Kobza; Christian Sticherling; Peter Ammann; Heiko Zerlik; Carine Stettler; Catherine Klersy; Frits Prinzen; Angelo Auricchio
Journal:  Indian Pacing Electrophysiol J       Date:  2017-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.